FibroBiologics (FBLG) Short-Term Debt issuances (2024 - 2025)
FibroBiologics (FBLG) posted quarterly Short-Term Debt issuances of -$4.4 million for Q4 2025, down 200.0% on a QoQ basis from $4.4 million in Q3 2025.
FibroBiologics (FBLG) Short-Term Debt issuances (2024 - 2025) Analysis & Trends
FibroBiologics has reported Short-Term Debt issuances for 2 years, with the latest figure at -$4.4 million in Q4 2025.
- Short-Term Debt issuances for Q4 2025 came in at -$4.4 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2025 was $4.4 million (up 662.2% YoY), and the FY2024 annual result was $574000.0, up 91.33% from the prior year.
- Short-Term Debt issuances slipped to -$4.4 million in Q4 2025, from $4.4 million in the prior quarter.
- Over five years, Short-Term Debt issuances peaked at $4.4 million in Q3 2025 and troughed at -$4.4 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Short-Term Debt issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | FibroBiologics | 8.97 Mn | 8.97 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4.38 Mn |
| Dec 31, 2025 | -4.38 Mn |
| Sep 30, 2024 | 287,000.00 |
| Sep 30, 2024 | 287,000.00 |
| Jun 30, 2024 | 172,000.00 |
| Jun 30, 2024 | 172,000.00 |
| Mar 31, 2024 | 115,000.00 |
| Mar 31, 2024 | 115,000.00 |